BALLESTRERO, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 29.456
AS - Asia 3.437
NA - Nord America 3.011
Continente sconosciuto - Info sul continente non disponibili 528
SA - Sud America 321
AF - Africa 66
OC - Oceania 10
Totale 36.829
Nazione #
IT - Italia 28.837
US - Stati Uniti d'America 2.803
SG - Singapore 1.349
CN - Cina 818
VN - Vietnam 584
BD - Bangladesh 336
FR - Francia 230
BR - Brasile 184
HK - Hong Kong 112
CA - Canada 96
DE - Germania 90
FI - Finlandia 75
AR - Argentina 71
GB - Regno Unito 47
JP - Giappone 44
IN - India 41
MX - Messico 37
IQ - Iraq 30
NL - Olanda 29
ID - Indonesia 26
EC - Ecuador 23
CH - Svizzera 19
ES - Italia 19
ZA - Sudafrica 17
IE - Irlanda 14
RU - Federazione Russa 14
PH - Filippine 13
MA - Marocco 12
HN - Honduras 11
TH - Thailandia 11
UA - Ucraina 11
UZ - Uzbekistan 11
CL - Cile 10
CR - Costa Rica 10
VE - Venezuela 10
AU - Australia 9
CO - Colombia 9
JM - Giamaica 9
PK - Pakistan 9
SE - Svezia 9
TR - Turchia 9
SV - El Salvador 8
GT - Guatemala 7
KE - Kenya 7
LT - Lituania 7
PL - Polonia 7
PY - Paraguay 7
TT - Trinidad e Tobago 7
AL - Albania 6
AT - Austria 6
NP - Nepal 6
DZ - Algeria 5
GR - Grecia 5
KR - Corea 5
PA - Panama 5
PR - Porto Rico 5
TN - Tunisia 5
BE - Belgio 4
EG - Egitto 4
RO - Romania 4
RS - Serbia 4
UY - Uruguay 4
BG - Bulgaria 3
ET - Etiopia 3
JO - Giordania 3
MM - Myanmar 3
NI - Nicaragua 3
PT - Portogallo 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AZ - Azerbaigian 2
BB - Barbados 2
BS - Bahamas 2
CY - Cipro 2
DK - Danimarca 2
GH - Ghana 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
MT - Malta 2
PE - Perù 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HU - Ungheria 1
KG - Kirghizistan 1
Totale 36.284
Città #
Genova 15.298
Genoa 8.394
Rapallo 2.675
Vado Ligure 1.873
Singapore 642
San Jose 631
Ashburn 358
Lauterbourg 207
Ho Chi Minh City 186
New York 139
Beijing 136
Milan 131
Hanoi 118
Council Bluffs 115
Hong Kong 107
Los Angeles 87
Helsinki 68
Frankfurt am Main 66
Santa Clara 65
Bordighera 55
Dallas 40
Tokyo 39
Montreal 35
Rome 35
Valenza 35
Buffalo 29
Chicago 27
Atlanta 26
Da Nang 25
São Paulo 24
Haiphong 23
Orem 23
Mexico City 21
Naples 21
Phoenix 19
Turin 18
Biên Hòa 15
Boardman 15
Memphis 15
Brooklyn 14
Johannesburg 14
Tianjin 14
Toronto 14
Zurich 14
City of London 13
Houston 13
London 13
Amsterdam 12
Charlotte 12
Columbus 12
Des Moines 12
Dublin 12
Can Tho 11
Newark 11
Nuremberg 11
Rovereto 11
Philadelphia 10
Baghdad 9
Buenos Aires 9
Delhi 9
Miami 9
Minneapolis 9
Paris 9
Piscataway 9
Rio de Janeiro 9
San Francisco 9
San José 9
Boston 8
Quảng Ngãi 8
Stockholm 8
The Bronx 8
Washington 8
Ancona 7
Birmingham 7
Bologna 7
Cardiff 7
Jacksonville 7
Kansas City 7
Madrid 7
Marseille 7
San Pedro Sula 7
Seattle 7
Sydney 7
Tashkent 7
Warsaw 7
Xi'an 7
Cagliari 6
Catania 6
Detroit 6
Dhaka 6
Florence 6
Hải Dương 6
Lappeenranta 6
Lawrenceville 6
Long Xuyen 6
Milwaukee 6
Modena 6
Mumbai 6
Palermo 6
Quito 6
Totale 32.371
Nome #
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 349
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 347
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 326
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. 286
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 279
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 269
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 262
HMGA2 overexpression in plycythemia vera with t(12;21) (q14;q22) 261
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 260
APO866 activity in hematologic malignancies: a preclinical in vitro study. 252
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 252
P-334 * Radiological assessments for select patients in neoadjuvant setting in rectal cancer: monoinstitutional experience 250
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 248
Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors and DNA repair. 243
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation 241
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 233
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics 230
DNA aneuploidy relationship with patient age and tobacco smoke in OPMDs/OSCCs 229
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 226
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia 223
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 219
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 218
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 214
Uncovering the genomic heterogeneity of multifocal breast cancer 214
Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancer 212
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 210
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 210
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 209
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 208
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 208
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 208
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. 207
Discovery of novel and selective SIRT6 inhibitors. 206
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 206
Ras-induced resistance to lapatinib is overcome by MEK inhibition 205
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 203
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 202
Sirt6 regulates dendritic cell differentiation, maturation, and function 202
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 202
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 200
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 199
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 199
Fasting potentiates the anticancer activity of tyrosin kinase inhibitors by strenghtening MAPK signalling inhibition. 197
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 196
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 195
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 195
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 192
Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. 192
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 192
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 191
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 191
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 190
Schlafen 11 Assessment in High-Grade Serous Ovarian Carcinoma: Phenotypic and Histological Distribution 190
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 190
Squalene epoxidase as a promising metabolic target in cancer treatment 189
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 189
EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition 187
Clinical predictors of late SARS-CoV-2 positivity in Italian internal medicine wards 187
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry. 186
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 186
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments. Concordance with experimental results. 185
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 185
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 185
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 183
Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors 183
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 181
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 181
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 180
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 180
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases 180
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 179
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 179
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 178
Frailty assessment in elective gastrointestinal oncogeriatric surgery: Predictors of one-year mortality and functional status 178
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 177
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 177
High-dose cyclophosphamide followed by gm-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells 176
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 175
Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol 175
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study 173
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 173
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 173
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions. 172
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 171
Nicotinamide Phosphoribosyltransferase As A Target In Inflammation-Related Disorders. 171
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals 171
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 170
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 170
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer 170
Molecular characterization of an Italian series of sporadic GISTs. 170
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer. 169
Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status 169
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells 168
The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level 168
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 167
Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 166
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 164
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 164
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 163
Immunotherapy with dendritic cells for cancer 162
Totale 20.223
Categoria #
all - tutte 114.352
article - articoli 110.485
book - libri 0
conference - conferenze 2.446
curatela - curatele 0
other - altro 0
patent - brevetti 359
selected - selezionate 0
volume - volumi 1.062
Totale 228.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.717 94 185 154 366 142 212 180 538 153 239 139 315
2022/20233.224 289 297 23 360 558 484 31 237 479 18 392 56
2023/20241.835 71 213 39 245 150 314 102 156 88 48 111 298
2024/20255.409 204 314 164 402 549 493 489 1.019 200 228 536 811
2025/20269.872 1.174 305 629 759 1.265 759 1.407 457 715 1.053 707 642
2026/2027780 780 0 0 0 0 0 0 0 0 0 0 0
Totale 36.829